All News

Patients need more help managing complicated meds than ever-and pharmacists are there to help.

The first test store in Des Plaines could be just the start.

The FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.

The failed Rite Aid/Walgreens merger might mean the end of business as usual.

Is your pharmacy's refrigerator maintaining the right temperature?

International Laboratories recalling one lot of bottles labeled 40-mg pravastatin.

When drug prices spike, health-care providers are forced to make tough choices.

FDA is alerting health professionals to a sterility breach with Vital Rx Inc. products.

Class action lawsuits claim that chains colluded with PBMs to overbill customers.

The recall affects a variety of distributors.

Pharmacy chains are forcing lower generic prices for their customers.

A youth education campaign about e-cigarettes is part of FDA’s tobacco/nicotine plan.

Here's the technology your pharmacy might have in the next 10 years.

How the FDA is prioritizing drugs that offer the biggest health gains.

The agency says that the reduction lines up with current demand for opioids.

How one product is making it easier for your patients to safely dispose of their medications.

Big changes for EpiPen and more in Express Scripts’ formulary.

A new study shows that supplement exposure rates have been increasing-pharmacists have a responsibility to slow those rates.

A compounding fraud scheme cost taxpayers millions-and could put two pharmacists in prison.

Aspace Packaging recalls two drugs due to potential mislabeling.

Looking for a new pharmacy job? You should probably avoid these states.

The American College of Apothecaries pharmacy conference will concentrate on improved pharmacy businesses.

The chain signs a deal with Fareva to take over its contract manufacturing business.

The maker of Androgel will face a series of trials after its most recent court loss.

Sometimes customers are people too.

Renflexis has wholesale cost 35% below Remicade.

A new study shows that a pharmacist-physician team can lower inappropriate drug use.